Clinical laboratory · 2025
A Case of Thrombocytopenia Caused by Gynostemma Pentaphyllum.
Клинический случайСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ding Lifeng, Lu Tao, Zhan Liya
Аннотация
BACKGROUND: The clinical harm of thrombocytopenia is significant, including bleeding, anemia, thrombosis, and increased risk of infection. Gynostemma pentaphyllum, a prominent traditional Chinese medicine, is clinically utilized to treat various conditions such as diabetes mellitus, hepatic fibrosis, hypertension, hyperlipidemia, and other disorders. This report details a case of a cerebral infarction patient who developed significant thrombocytope-nia following treatment with Gynostemma pentaphyllum. This case underscores the importance of monitoring platelet counts in patients using Gynostemma pentaphyllum.
METHODS: The patient's platelet counts were measured using a fully automated blood cell counter. Her whole blood cell concentrations were assessed before and after discontinuation of Gynostemma pentaphyllum.
RESULTS: Initial blood tests revealed leukocyte and platelet concentrations of 3.27 x 109/L and 6.0 x 109/L, respectively, after the patient had used Gynostemma pentaphyllum continuously for over three months. Post-discontinuation, two subsequent blood tests showed leukocyte counts of 5.26 x 109/L and 5.52 x 109/L, and platelet counts rebounded to 156 x 109/L.
CONCLUSIONS: Gynostemma pentaphyllum may induce thrombocytopenia. Patients on long-term therapy with this medication should have their platelet levels closely monitored.
METHODS: The patient's platelet counts were measured using a fully automated blood cell counter. Her whole blood cell concentrations were assessed before and after discontinuation of Gynostemma pentaphyllum.
RESULTS: Initial blood tests revealed leukocyte and platelet concentrations of 3.27 x 109/L and 6.0 x 109/L, respectively, after the patient had used Gynostemma pentaphyllum continuously for over three months. Post-discontinuation, two subsequent blood tests showed leukocyte counts of 5.26 x 109/L and 5.52 x 109/L, and platelet counts rebounded to 156 x 109/L.
CONCLUSIONS: Gynostemma pentaphyllum may induce thrombocytopenia. Patients on long-term therapy with this medication should have their platelet levels closely monitored.